Nihon Kohden Corp
TSE:6849

Watchlist Manager
Nihon Kohden Corp Logo
Nihon Kohden Corp
TSE:6849
Watchlist
Price: 1 580.5 JPY -2.08% Market Closed
Market Cap: 270.2B JPY

Nihon Kohden Corp
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nihon Kohden Corp
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Nihon Kohden Corp
TSE:6849
Cash from Operating Activities
¥21.7B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
6%
Paramount Bed Holdings Co Ltd
TSE:7817
Cash from Operating Activities
¥10B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
2%
Terumo Corp
TSE:4543
Cash from Operating Activities
¥211.9B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
10%
Olympus Corp
TSE:7733
Cash from Operating Activities
¥152B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
9%
Sysmex Corp
TSE:6869
Cash from Operating Activities
¥79.8B
CAGR 3-Years
19%
CAGR 5-Years
8%
CAGR 10-Years
8%
JEOL Ltd
TSE:6951
Cash from Operating Activities
¥23.1B
CAGR 3-Years
2%
CAGR 5-Years
42%
CAGR 10-Years
9%
No Stocks Found

Nihon Kohden Corp
Glance View

Market Cap
257.7B JPY
Industry
Health Care

Nihon Kohden Corp., founded in 1951, has evolved into a pioneering force in the medical technology landscape, blending innovation with a storied heritage. This Tokyo-based firm established its foothold by developing advanced medical electronic devices, initially focusing on EEG (electroencephalography) machines. As medical science rapidly advanced, Nihon Kohden expanded its portfolio to include a range of diagnostic and monitoring equipment. Today, the company's product line encompasses patient monitors, defibrillators, electrocardiographs, and clinical information systems, serving various healthcare domains. This focus on critical care and diagnostics creates consistent demand across global hospitals and clinics, reinforcing its reputation as a dependable partner in medical excellence. Financially, Nihon Kohden's business model thrives on a dual revenue structure: product sales and after-sales service. By manufacturing and distributing complex equipment directly and through a network of distributors, the company captures a significant share of initial capital expenditure in healthcare institutions. Furthermore, it enhances this income by offering ongoing equipment maintenance, training, and customer support, forming long-term relationships with healthcare providers. These services ensure not only a steady revenue stream beyond the initial sale but also brand loyalty and trust in an industry where precision and reliability are paramount. As it continues to innovate, Nihon Kohden's commitment to addressing the evolving needs of healthcare practitioners fortifies its market position and operational success.

Nihon Kohden Corp Intrinsic Value
HIDDEN
Show

See Also

What is Nihon Kohden Corp's Cash from Operating Activities?
Cash from Operating Activities
21.7B JPY

Based on the financial report for Jun 30, 2025, Nihon Kohden Corp's Cash from Operating Activities amounts to 21.7B JPY.

What is Nihon Kohden Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
6%

Over the last year, the Cash from Operating Activities growth was 116%. The average annual Cash from Operating Activities growth rates for Nihon Kohden Corp have been 1% over the past three years , 8% over the past five years , and 6% over the past ten years .

Back to Top